{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:30:33Z","timestamp":1793507433456,"version":"4.5.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.idc.2021.03.007","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T01:22:39Z","timestamp":1621300959000},"page":"389-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":244,"title":["Candidemia and Invasive Candidiasis"],"prefix":"10.1016","volume":"35","author":[{"given":"Todd P.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.idc.2021.03.007_bib1","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in Prevalence Of Health Care-Associated Infections in U.S. Hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.idc.2021.03.007_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY Antimicrobial Surveillance Program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid2301.161198","article-title":"Epidemiology of hospitalizations associated with invasive Candidiasis, United States, 2002-2012(1)","volume":"23","author":"Strollo","year":"2016","journal-title":"Emerging Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.007_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6808a1","article-title":"Population-based active surveillance for culture-confirmed Candidemia - Four Sites, United States, 2012-2016","volume":"68","author":"Toda","year":"2019","journal-title":"MMWR Surveill Summ"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.03.007_bib5","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY antifungal surveillance program: results for Candida Species From 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004-2008","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib9","doi-asserted-by":"crossref","first-page":"ofx253","DOI":"10.1093\/ofid\/ofx253","article-title":"Creation and assessment of a clinical predictive calculator and mortality associated with Candida Krusei bloodstream infections","volume":"5","author":"Kronen","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idc.2021.03.007_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mib.2019.05.008","article-title":"Global epidemiology of emerging Candida auris","volume":"52","author":"Rhodes","year":"2019","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01588-17","article-title":"Candida auris: an emerging fungal pathogen","volume":"56","author":"Spivak","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/microorganisms8020181","article-title":"Candida auris, an agent of hospital-associated outbreaks: which challenging issues do we need to have in mind?","volume":"8","author":"Sabino","year":"2020","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrmicro2711","article-title":"Candida albicans morphogenesis and host defence: discriminating invasion from colonization","volume":"10","author":"Gow","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/viru.22913","article-title":"Candida albicans pathogenicity mechanisms","volume":"4","author":"Mayer","year":"2013","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib15","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/AAC.48.9.3291-3297.2004","article-title":"Penetration of Candida biofilms by antifungal agents","volume":"48","author":"Al-Fattani","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib16","first-page":"21","article-title":"Contributions of the Biofilm Matrix to Candida Pathogenesis","volume":"6","author":"Nett","year":"2020","journal-title":"J\u00a0Fungi (Basel)"},{"key":"10.1016\/j.idc.2021.03.007_bib17","doi-asserted-by":"crossref","first-page":"528521","DOI":"10.1155\/2012\/528521","article-title":"Fungal biofilm resistance","volume":"2012","author":"Ramage","year":"2012","journal-title":"Int J Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.007_bib18","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1128\/AAC.00684-06","article-title":"Candida albicans biofilms produce antifungal-tolerant persister cells","volume":"50","author":"LaFleur","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib19","doi-asserted-by":"crossref","first-page":"e1007301","DOI":"10.1371\/journal.ppat.1007301","article-title":"Fungal persister cells: the basis for recalcitrant infections?","volume":"14","author":"Wuyts","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.idc.2021.03.007_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fcimb.2020.00034","article-title":"Monocytes and the host response to fungal pathogens","volume":"10","author":"Heung","year":"2020","journal-title":"Front Cell Infect Microbiol."},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1556\/1886.2019.00011","article-title":"Immune response in bacterial and Candida Sepsis","volume":"9","author":"Patricio","year":"2019","journal-title":"Eur J Microbiol Immunol"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \"missing 50%\" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/504810","article-title":"Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study","volume":"43","author":"Garey","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib24","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/1469-0691.12210","article-title":"Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species","volume":"20","author":"Lacroix","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib26","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1128\/JCM.01405-12","volume":"50","author":"Tan","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib27","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1128\/JCM.00389-09","article-title":"Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates","volume":"47","author":"Marklein","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib28","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1128\/JCM.43.6.2909-2912.2005","article-title":"Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in\u00a0situ hybridization probe for characterization of yeast isolates from blood cultures","volume":"43","author":"Wilson","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib29","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1128\/JCM.06148-11","article-title":"Evaluation of the yeast traffic light PNA FISH probes for identification of Candida species from positive blood cultures","volume":"50","author":"Hall","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib30","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciq206","article-title":"beta-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis","volume":"52","author":"Karageorgopoulos","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.idc.2021.03.007_bib31","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.2169\/internalmedicine.50.6175","article-title":"Diagnosis of invasive fungal disease using serum (1-->3)-beta-D-glucan: a bivariate meta-analysis","volume":"50","author":"Lu","year":"2011","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JCM.05267-11","article-title":"Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis","volume":"50","author":"Onishi","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"182","key":"10.1016\/j.idc.2021.03.007_bib33","doi-asserted-by":"crossref","first-page":"182ra54","DOI":"10.1126\/scitranslmed.3005377","article-title":"T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood","volume":"5","author":"Neely","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib34","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.03.007_bib35","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cix1095","article-title":"Detecting infections rapidly and easily for Candidemia Trial, Part 2 (DIRECT2): a prospective, multicenter study of the T2Candida Panel","volume":"66","author":"Clancy","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/JCM.01679-15","article-title":"Evaluation of the FilmArray blood culture identification panel: results of a multicenter controlled trial","volume":"54","author":"Salimnia","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/JCM.01602-10","article-title":"PCR diagnosis of invasive candidiasis: systematic review and meta-analysis","volume":"49","author":"Avni","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib38","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/528690","article-title":"A\u00a0prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults","volume":"46","author":"McMullan","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib39","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/JCM.02460-10","article-title":"Multiplex PCR allows rapid and accurate diagnosis of bloodstream infections in newborns and children with suspected sepsis","volume":"49","author":"Lucignano","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.idc.2021.03.007_bib40","series-title":"Reference method for Broth Dilution antifungal susceptibility testing of yeasts","year":"2017"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.03.007_bib42","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/JCM.05047-11","article-title":"Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida","volume":"49","author":"Pfaller","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib43","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1128\/JCM.00248-12","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution","volume":"50","author":"Pfaller","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.19.2.435-447.2006","article-title":"Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing","volume":"19","author":"Pfaller","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib46","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","article-title":"Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata","volume":"50","author":"Pfaller","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.diagmicrobio.2010.06.015","article-title":"Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009)","volume":"68","author":"Pfaller","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.007_bib48","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3201\/eid1801.110556","article-title":"Candida spp. with acquired echinocandin resistance, France, 2004-2010","volume":"18","author":"Dannaoui","year":"2012","journal-title":"Emerging Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.idc.2021.03.007_bib51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.15585\/mmwr.mm6619a7","article-title":"Notes from the field: ongoing transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017","volume":"66","author":"Tsay","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.idc.2021.03.007_bib52","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.05947-11","article-title":"Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection","volume":"56","author":"Ben-Ami","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.idc.2021.03.007_bib53","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jac\/dkq136","article-title":"Candidaemia associated with decreased in\u00a0vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?","volume":"65","author":"Oxman","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib54","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016\u00a0Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib55","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","article-title":"A\u00a0multicenter study of septic shock due to candidemia: outcomes and predictors of mortality","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib56","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of Candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib57","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib58","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.amjmed.2010.03.021","article-title":"The clinical and prognostic importance of positive blood cultures in adults","volume":"123","author":"Pien","year":"2010","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10096-009-0843-0","article-title":"Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials","volume":"29","author":"Horn","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2021.03.007_bib60","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib62","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.03.007_bib63","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/376906","article-title":"A\u00a0prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2021.03.007_bib64","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.007_bib65","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib66","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/jac\/dkr511","article-title":"Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes","volume":"67","author":"Grim","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/13693786.2010.512300","article-title":"Early treatment of candidemia in adults: a review","volume":"49","author":"Ostrosky-Zeichner","year":"2011","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib68","first-page":"11","article-title":"Invasive Candidiasis in infants and children: recent advances in epidemiology, diagnosis, and treatment","volume":"5","author":"Walsh","year":"2019","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib69","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1542\/peds.2013-0671","article-title":"Changes in the incidence of candidiasis in neonatal intensive care units","volume":"133","author":"Aliaga","year":"2014","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/cid\/cit679","article-title":"Decreasing rates of invasive candidiasis in pediatric hospitals across the United States","volume":"58","author":"Fisher","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib71","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1542\/peds.2011-3620","article-title":"Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009","volume":"130","author":"Chitnis","year":"2012","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib72","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22\u00a0months","volume":"117","author":"Benjamin","year":"2006","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib73","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/513196","article-title":"Outcomes attributable to neonatal candidiasis","volume":"44","author":"Zaoutis","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/cid\/cir800","article-title":"Outcomes following candiduria in extremely low birth weight infants","volume":"54","author":"Wynn","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.idc.2021.03.007_bib75","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/jama.292.19.2357","article-title":"Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection","volume":"292","author":"Stoll","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.jp.7211628","article-title":"Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures","volume":"27","author":"Cohen-Wolkowiez","year":"2007","journal-title":"J\u00a0Perinatol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib77","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/313973","article-title":"Candidal meningitis in neonates: a 10-year review","volume":"31","author":"Fernandez","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"suppl_1","key":"10.1016\/j.idc.2021.03.007_bib78","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/jpids\/pix039","article-title":"International collaborative on contemporary epidemiology and diagnosis of invasive fungal disease in children","volume":"6","author":"Steinbach","year":"2017","journal-title":"J\u00a0Pediatr Infect Dis Soc"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.jp.7211628","article-title":"Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't","volume":"27","author":"Cohen-Wolkowiez","year":"2007","journal-title":"J\u00a0Perinatol"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib80","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2021.03.007_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijid.2018.09.016","article-title":"Outcomes in patients with fungal endocarditis: a multicenter observational cohort study","volume":"77","author":"Siciliano","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib82","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3201\/eid2404.171807","article-title":"Reemergence of intravenous drug use as risk factor for Candidemia, Massachusetts, USA","volume":"24","author":"Poowanawittayakom","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib83","doi-asserted-by":"crossref","first-page":"130","DOI":"10.29074\/ascls.25.3.130","article-title":"Candidal endocarditis presenting with bilateral lower limb ischemia. Case Reports","volume":"25","author":"Card","year":"2012","journal-title":"Clin Lab Sci"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib84","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.04867-14","article-title":"Candida infective endocarditis: an observational cohort study with a focus on therapy","volume":"59","author":"Arnold","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib85","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1086\/516125","article-title":"Pacemaker endocarditis due to Candida albicans: case report and review. Case Reports Review","volume":"25","author":"Joly","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000441-200109000-00010","article-title":"Implantable cardioverter-defibrillator endocarditis secondary to Candida albicans. Case Reports Review","volume":"322","author":"Brown","year":"2001","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib87","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1111\/j.1439-0507.2010.01866.x","article-title":"Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines","volume":"54","author":"Halawa","year":"2011","journal-title":"Rev Mycoses"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10840-005-3246-x","article-title":"Septic shock induced from an implantable cardioverter-defibrillator lead-associated Candida albicans vegetation. Case Reports","volume":"14","author":"Hindupur","year":"2005","journal-title":"J\u00a0Interv Card Electrophysiol"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib89","first-page":"176","article-title":"Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata. Case Reports","volume":"41","author":"Roger","year":"2000","journal-title":"J\u00a0Infect"},{"issue":"1\u20132","key":"10.1016\/j.idc.2021.03.007_bib90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11046-012-9591-2","article-title":"Micafungin for Candida albicans pacemaker-associated endocarditis: a case report and review of the literature. Case Reports Review","volume":"175","author":"Tascini","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.idc.2021.03.007_bib91","article-title":"Management of systemic fungal infections in the presence of a cardiac implantable electronic device: a systematic review","author":"Baman","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.007_bib92","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/650454","article-title":"Risk factors and outcomes of fungal ventricular-assist device infections. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't","volume":"50","author":"Aslam","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib93","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1540-8191.2009.00919.x","article-title":"Fungemia associated with left ventricular assist device support","volume":"24","author":"Bagdasarian","year":"2009","journal-title":"J\u00a0Card Surg"},{"issue":"5","key":"10.1016\/j.idc.2021.03.007_bib94","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.healun.2013.02.002","article-title":"Infectious complications and outcomes in children supported with left ventricular assist devices. Research Support, Non-U.S. Gov't","volume":"32","author":"Cabrera","year":"2013","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib95","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/509640","article-title":"Candidemia in patients with ventricular assist devices","volume":"44","author":"Shoham","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib96","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/cid\/cis660","article-title":"Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011)","volume":"55","author":"Gamaletsou","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib97","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diagmicrobio.2012.02.004","article-title":"Two hundred and eleven cases of Candida osteomyelitis: 17 case reports and a review of the literature","volume":"73","author":"Slenker","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/23744235.2016.1219456","article-title":"Candida-induced prosthetic joint infection. A literature review including 72 cases and a case report","volume":"49","author":"Cobo","year":"2017","journal-title":"Infect Dis (Lond)"},{"issue":"15","key":"10.1016\/j.idc.2021.03.007_bib99","doi-asserted-by":"crossref","first-page":"e19735","DOI":"10.1097\/MD.0000000000019735","article-title":"Prosthetic joint infection due to Candida species: case series and review of literature","volume":"99","author":"Saconi","year":"2020","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005792-200303000-00004","article-title":"Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center","volume":"82","author":"Binder","year":"2003","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.idc.2021.03.007_bib101","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1592\/phco.27.12.1711","article-title":"Candida endophthalmitis: focus on current and future antifungal treatment options","volume":"27","author":"Khan","year":"2007","journal-title":"Rev Pharmacother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib102","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajo.2011.06.020","article-title":"Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't","volume":"153","author":"Lingappan","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib103","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/bjo.2007.133405","article-title":"Ocular candidiasis: a review","volume":"92","author":"Shah","year":"2008","journal-title":"Rev Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib104","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.1989.00390100056014","article-title":"Prospective study of Candida endophthalmitis in hospitalized patients with candidemia","volume":"149","author":"Brooks","year":"1989","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/cid\/cir355","article-title":"Ocular manifestations of candidemia","volume":"53","author":"Oude Lashof","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib106","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/j.1439-0507.2012.02182.x","article-title":"New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis","volume":"55","author":"Rammaert","year":"2012","journal-title":"Mycoses"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib107","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1365-2141.1999.01592.x","article-title":"Hepatosplenic candidiasis in patients with acute leukaemia","volume":"106","author":"Sallah","year":"1999","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.007_bib108","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive Candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib109","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/01.CCM.0000201889.39443.D2","article-title":"Candida as a risk factor for mortality in peritonitis","volume":"34","author":"Montravers","year":"2006","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib110","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.CCM.0000202129.19154.64","article-title":"Candida in the peritoneum: passenger or pathogen?","volume":"34","author":"Rex","year":"2006","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib111","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clineuro.2009.11.011","article-title":"Candida parapsilosis meningitis associated with shunt infection in an adult male","volume":"112","author":"Bagheri","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib112","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00701-011-0990-9","article-title":"Candida infection of the central nervous system following neurosurgery: a 12-year review","volume":"153","author":"O'Brien","year":"2011","journal-title":"Acta Neurochir"},{"issue":"25","key":"10.1016\/j.idc.2021.03.007_bib113","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"9572","key":"10.1016\/j.idc.2021.03.007_bib114","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2021.03.007_bib115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2334-11-261","article-title":"Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome","volume":"11","author":"Reboli","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2021.03.007_bib116","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2021.03.007_bib117","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/cid\/ciy827","article-title":"Isavuconazole versus caspofungin in the treatment of candidemia and other invasive Candida Infections: the ACTIVE Trial","volume":"68","author":"Kullberg","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2021.03.007_bib118","article-title":"Rezafungin versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive Candidiasis- The STRIVE Trial","author":"Thompson","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib119","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamaophthalmol.2019.0733","article-title":"Utility of ophthalmologic screening for patients with candida bloodstream infections: a systematic review","volume":"137","author":"Breazzano","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.idc.2021.03.007_bib120","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/598933","volume":"48","author":"Betts","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib121","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/423378","article-title":"A\u00a0randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. Clinical Trial Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't","volume":"39","author":"Krause","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"9572","key":"10.1016\/j.idc.2021.03.007_bib122","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.idc.2021.03.007_bib123","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/501020","article-title":"Micafungin: a new echinocandin. Research Support, Non-U.S. Gov't Review","volume":"42","author":"Chandrasekar","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.03.007_bib124","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/375080","article-title":"Caspofungin","volume":"36","author":"Deresinski","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1086\/505204","article-title":"Anidulafungin: a novel echinocandin. Research Support, Non-U.S. Gov't Review","volume":"43","author":"Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib126","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10096-012-1754-z","article-title":"A\u00a0double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis. Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov't","volume":"32","author":"Kohno","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib127","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In\u00a0vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. Research Support, Non-U.S. Gov't","volume":"46","author":"Pfaller","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.01590-09","article-title":"Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. Research Support, Non-U.S. Gov't","volume":"48","author":"Pfaller","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.idc.2021.03.007_bib129","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1128\/JCM.05047-11","article-title":"Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. Research Support, Non-U.S. Gov't","volume":"49","author":"Pfaller","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"12","key":"10.1016\/j.idc.2021.03.007_bib130","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1093\/jac\/dkw305","article-title":"Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12)","volume":"71","author":"Chiotos","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijantimicag.2011.02.016","article-title":"Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)","volume":"38","author":"Pfaller","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib132","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JCM.01398-10","article-title":"Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)","volume":"49","author":"Pfaller","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib133","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1128\/AAC.01144-13","article-title":"Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure","volume":"57","author":"Lewis","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib134","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.01674-13","article-title":"Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates","volume":"58","author":"Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"7\u20138","key":"10.1016\/j.idc.2021.03.007_bib135","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1345\/aph.1R020","article-title":"Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Research Support, Non-U.S. Gov't Review","volume":"46","author":"Beyda","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.idc.2021.03.007_bib136","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1128\/AAC.00136-13","article-title":"Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure. Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't","volume":"57","author":"Shields","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib137","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Review","volume":"48","author":"Bruggemann","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.idc.2021.03.007_bib138","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM199411173312001","article-title":"A\u00a0randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute","volume":"331","author":"Rex","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib139","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1086\/374850","article-title":"A\u00a0randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects","volume":"36","author":"Rex","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00199879","article-title":"Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Clinical Trial Randomized Controlled Trial","volume":"46","author":"Zimmermann","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.idc.2021.03.007_bib141","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1128\/AAC.39.5.1154","article-title":"Fluconazole penetration in cerebral parenchyma in humans at steady state","volume":"39","author":"Thaler","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib142","first-page":"379A","article-title":"Intravitreous penetration of fluconazole during endophthalmitis","volume":"3","author":"Tod","year":"1997","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib143","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.32.3.369","article-title":"Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis","volume":"32","author":"Tucker","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib144","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A\u00a0randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clinical Trial Comparative Study Multicenter Study Randomized Controlled Trial","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9495","key":"10.1016\/j.idc.2021.03.007_bib145","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(05)67490-9","volume":"366","author":"Kullberg","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2021.03.007_bib146","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1439-0507.1996.tb00514.x","article-title":"[Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis]","volume":"39","author":"Eichel","year":"1996","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2021.03.007_bib147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2334-13-219","article-title":"Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial. Clinical Trial, Phase III Multicenter Study Research Support, Non-U.S. Gov't","volume":"13","author":"Mootsikapun","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2021.03.007_bib148","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/myc.12094","article-title":"An open-label study of anidulafungin for the treatment of candidaemia\/invasive candidiasis in Latin America. Clinical Trial, Phase IV Multicenter Study Research Support, Non-U.S. Gov't","volume":"57","author":"Nucci","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.idc.2021.03.007_bib149","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-14-97","article-title":"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial","volume":"14","author":"Vazquez","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181e9441b","article-title":"Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis. Meta-Analysis Research Support, Non-U.S. Gov't Review","volume":"89","author":"Safdar","year":"2010","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.idc.2021.03.007_bib151","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1086\/516353","article-title":"Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases","volume":"26","author":"Walsh","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2021.03.007_bib152","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/319211","article-title":"Mortality and costs of acute renal failure associated with amphotericin B therapy. Research Support, Non-U.S. Gov't","volume":"32","author":"Bates","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib153","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/jac\/dkz277","article-title":"MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis","volume":"74","author":"Spec","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.idc.2021.03.007_bib154","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00656-20","article-title":"Manogepix (APX001A) in\u00a0vitro activity against Candida auris: head-to-head comparison of EUCAST and CLSI MICs","volume":"64","author":"Arendrup","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.idc.2021.03.007_bib155","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02198-19","article-title":"The Novel Arylamidine T-2307 Demonstrates In\u00a0Vitro and In\u00a0Vivo Activity against Candida auris","volume":"64","author":"Wiederhold","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2021.03.007_bib156","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Multicenter Study Randomized Controlled Trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.idc.2021.03.007_bib157","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1097\/01.CCM.0000148226.95597.7E","article-title":"Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?","volume":"32","author":"Ostrosky-Zeichner","year":"2004","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.idc.2021.03.007_bib158","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/cid\/ciu074","article-title":"MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting","volume":"58","author":"Ostrosky-Zeichner","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2021.03.007_bib159","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00134-005-2794-y","article-title":"Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Meta-Analysis Review","volume":"31","author":"Cruciani","year":"2005","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.idc.2021.03.007_bib160","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/01.CCM.0000208357.05675.C3","article-title":"Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Comment Meta-Analysis","volume":"34","author":"Vardakas","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2021.03.007_bib161","article-title":"Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients","author":"Playford","year":"2001","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552021000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:28:57Z","timestamp":1760196537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552021000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":161,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0891552021000179"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.007","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candidemia and Invasive Candidiasis","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2021.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}